We aimed to elucidate the regulatory mechanism of exosomal lnc-MMP2-2 in lung cancer brain pro-metastases and examine whether it could be a promising therapeutic target for patients with NSCLC. This evidence concerns the gene MMP2 and lung carcinoma.